首页 > 最新文献

Global Rheumatology最新文献

英文 中文
Vacinas seguras e eficazes contra o covid-19 nos pacientes reumáticos 风湿病患者安全有效的covid-19疫苗
Pub Date : 2022-08-09 DOI: 10.46856/grp.27.ept132
Estefanía Fajardo
Qual é a segurança e eficácia das vacinas na América Latina e especificamente em pacientes reumáticos da região? Diferentes grupos de pesquisa se propõem a realizar estes diferentes estudos e análises que permitem ter uma maior segurança e suporte na tomada de decisões.
疫苗在拉丁美洲,特别是在该地区风湿病患者中安全性和有效性如何?不同的研究小组提出进行这些不同的研究和分析,以提供更大的安全性和决策支持。
{"title":"Vacinas seguras e eficazes contra o covid-19 nos pacientes reumáticos","authors":"Estefanía Fajardo","doi":"10.46856/grp.27.ept132","DOIUrl":"https://doi.org/10.46856/grp.27.ept132","url":null,"abstract":"Qual é a segurança e eficácia das vacinas na América Latina e especificamente em pacientes reumáticos da região? Diferentes grupos de pesquisa se propõem a realizar estes diferentes estudos e análises que permitem ter uma maior segurança e suporte na tomada de decisões.","PeriodicalId":187344,"journal":{"name":"Global Rheumatology","volume":"31 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-08-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127789527","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safe and effective vaccines against covid-19 in rheumatic patients 风湿病患者安全有效的covid-19疫苗
Pub Date : 2022-08-09 DOI: 10.46856/grp.27.et132
E. Fajardo
What is the safety and efficacy of vaccines in Latin America and specifically in rheumatic patients in the region? Different research groups set themselves the task of carrying out these different studies and analyzes that allow greater security and support in decision-making
在拉丁美洲,特别是在该地区的风湿病患者中,疫苗的安全性和有效性如何?不同的研究小组为自己设定了开展这些不同的研究和分析的任务,以便在决策时获得更大的保障和支持
{"title":"Safe and effective vaccines against covid-19 in rheumatic patients","authors":"E. Fajardo","doi":"10.46856/grp.27.et132","DOIUrl":"https://doi.org/10.46856/grp.27.et132","url":null,"abstract":"What is the safety and efficacy of vaccines in Latin America and specifically in rheumatic patients in the region? Different research groups set themselves the task of carrying out these different studies and analyzes that allow greater security and support in decision-making","PeriodicalId":187344,"journal":{"name":"Global Rheumatology","volume":"47 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-08-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114831473","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multicenter studies and registries, PANLAR research bets 多中心研究和登记,panar研究押注
Pub Date : 2022-08-09 DOI: 10.46856/grp.27.et133
E. Fajardo
Registries evaluating aspects of rheumatoid arthritis, multicenter studies of axial spondyloarthritis, as well as characterization, review and analysis of different pathologies are part of the research presented at the PANLAR 2022 Congress.
类风湿关节炎的登记评估,轴型脊柱炎的多中心研究,以及不同病理的表征,回顾和分析是PANLAR 2022年大会上提出的研究的一部分。
{"title":"Multicenter studies and registries, PANLAR research bets","authors":"E. Fajardo","doi":"10.46856/grp.27.et133","DOIUrl":"https://doi.org/10.46856/grp.27.et133","url":null,"abstract":"Registries evaluating aspects of rheumatoid arthritis, multicenter studies of axial spondyloarthritis, as well as characterization, review and analysis of different pathologies are part of the research presented at the PANLAR 2022 Congress.","PeriodicalId":187344,"journal":{"name":"Global Rheumatology","volume":"98 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-08-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122880821","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
O impacto da covid-19 em pacientes com doenças autoimunes covid-19对自身免疫性疾病患者的影响
Pub Date : 2022-08-09 DOI: 10.46856/grp.27.ept131
Estefanía Fajardo
É mais frequente o covid em pacientes com doenças autoimunes? É mais ou menos grave nesses pacientes? É mais ou menos mortal? Perguntas que buscam uma resposta através destas investigações e análises apresentadas no congresso.
covid在自身免疫性疾病患者中更常见吗?这些病人是更严重还是更不严重?它是致命的还是致命的?这些问题通过提交给国会的调查和分析寻求答案。
{"title":"O impacto da covid-19 em pacientes com doenças autoimunes","authors":"Estefanía Fajardo","doi":"10.46856/grp.27.ept131","DOIUrl":"https://doi.org/10.46856/grp.27.ept131","url":null,"abstract":"É mais frequente o covid em pacientes com doenças autoimunes? É mais ou menos grave nesses pacientes? É mais ou menos mortal? Perguntas que buscam uma resposta através destas investigações e análises apresentadas no congresso.","PeriodicalId":187344,"journal":{"name":"Global Rheumatology","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-08-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129147932","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The impact of covid-19 on patients with autoimmune diseases covid-19对自身免疫性疾病患者的影响
Pub Date : 2022-08-09 DOI: 10.46856/grp.27.et131
E. Fajardo
Is covid more frequent in patients with autoimmune diseases? Is it more or less severe in these patients? Is it more or less deadly? Questions that seek an answer through these investigations and analyzes presented at the congress.
covid在自身免疫性疾病患者中更常见吗?这些患者的病情是严重还是不严重?它是致命的还是致命的?通过这些调查和分析在大会上提出的问题寻求答案。
{"title":"The impact of covid-19 on patients with autoimmune diseases","authors":"E. Fajardo","doi":"10.46856/grp.27.et131","DOIUrl":"https://doi.org/10.46856/grp.27.et131","url":null,"abstract":"Is covid more frequent in patients with autoimmune diseases? Is it more or less severe in these patients? Is it more or less deadly? Questions that seek an answer through these investigations and analyzes presented at the congress.","PeriodicalId":187344,"journal":{"name":"Global Rheumatology","volume":"2 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-08-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"117058038","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PANLAR 2022: an overview of the scientific program panar 2022:科学计划概述
Pub Date : 2022-08-01 DOI: 10.46856/grp.27.et130
E. Fajardo
Dr. Licia Mota, president of the Scientific Committee, explains the evaluation of the submitted papers and the main topics that will be addressed from August 10 to 12 in Miami.
科学委员会主席Licia Mota博士解释了对提交的论文的评估和将于8月10日至12日在迈阿密举行的主要议题。
{"title":"PANLAR 2022: an overview of the scientific program","authors":"E. Fajardo","doi":"10.46856/grp.27.et130","DOIUrl":"https://doi.org/10.46856/grp.27.et130","url":null,"abstract":"Dr. Licia Mota, president of the Scientific Committee, explains the evaluation of the submitted papers and the main topics that will be addressed from August 10 to 12 in Miami.","PeriodicalId":187344,"journal":{"name":"Global Rheumatology","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131341821","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PANLAR 2022: una visión general del programa científico PANLAR 2022:科学计划概述
Pub Date : 2022-08-01 DOI: 10.46856/grp.27.e130
E. Fajardo
La doctora Licia Mota, presidenta del Comité Científico, explica la evaluación de los trabajos presentados y los temas principales que se abordarán del 10 al 12 de agosto en Miami.
科学委员会主席Licia Mota博士解释了对提交的论文的评估以及将于8月10日至12日在迈阿密讨论的主要主题。
{"title":"PANLAR 2022: una visión general del programa científico","authors":"E. Fajardo","doi":"10.46856/grp.27.e130","DOIUrl":"https://doi.org/10.46856/grp.27.e130","url":null,"abstract":"La doctora Licia Mota, presidenta del Comité Científico, explica la evaluación de los trabajos presentados y los temas principales que se abordarán del 10 al 12 de agosto en Miami.","PeriodicalId":187344,"journal":{"name":"Global Rheumatology","volume":"42 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"117286096","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Covid-19, winners and losers Covid-19,赢家和输家
Pub Date : 2022-08-01 DOI: 10.46856/grp.22.et129
Elias Forero Illera
Recent publications show other unexpected winners in this fight against viruses: drinks based con citrus fruits prepared by grandmothers since immemorial times.
最近的出版物显示,在这场对抗病毒的战斗中,还有其他意想不到的赢家:从远古时代起,祖母们就在调制柑橘类水果制成的饮料。
{"title":"Covid-19, winners and losers","authors":"Elias Forero Illera","doi":"10.46856/grp.22.et129","DOIUrl":"https://doi.org/10.46856/grp.22.et129","url":null,"abstract":"Recent publications show other unexpected winners in this fight against viruses: drinks based con citrus fruits prepared by grandmothers since immemorial times.","PeriodicalId":187344,"journal":{"name":"Global Rheumatology","volume":"16 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131800700","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Covid-19, vencedores e perdedores Covid-19,赢家和输家
Pub Date : 2022-08-01 DOI: 10.46856/grp.22.ept129
Elias Forero Illera
Publicações recentes mostram outros vencedores inesperados nesta luta contra os vírus: são as misturas preparadas pelas avós desde tempos imemoriais à base de frutas cítricas
最近的出版物显示了在这场对抗病毒的斗争中其他意想不到的赢家:自古以来,祖母们就用柑橘类水果准备了混合物
{"title":"Covid-19, vencedores e perdedores","authors":"Elias Forero Illera","doi":"10.46856/grp.22.ept129","DOIUrl":"https://doi.org/10.46856/grp.22.ept129","url":null,"abstract":"Publicações recentes mostram outros vencedores inesperados nesta luta contra os vírus: são as misturas preparadas pelas avós desde tempos imemoriais à base de frutas cítricas","PeriodicalId":187344,"journal":{"name":"Global Rheumatology","volume":"390 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124598616","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PANLAR 2022: uma visão geral do programa científico PANLAR 2022:科学计划概述
Pub Date : 2022-08-01 DOI: 10.46856/grp.27.ept130
Estefanía Fajardo
A Dra. Licia Mota, presidente do Comitê Científico, explica a avaliação dos trabalhos apresentados e os principais temas que serão abordados do dia 10 ao dia 12 de agosto em Miami.
博士。科学委员会主席Licia Mota解释了对提交的论文的评估,以及将于8月10日至12日在迈阿密讨论的主要主题。
{"title":"PANLAR 2022: uma visão geral do programa científico","authors":"Estefanía Fajardo","doi":"10.46856/grp.27.ept130","DOIUrl":"https://doi.org/10.46856/grp.27.ept130","url":null,"abstract":"A Dra. Licia Mota, presidente do Comitê Científico, explica a avaliação dos trabalhos apresentados e os principais temas que serão abordados do dia 10 ao dia 12 de agosto em Miami.","PeriodicalId":187344,"journal":{"name":"Global Rheumatology","volume":"16 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130620178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Global Rheumatology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1